Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix for Fertility Enhancement
NCT04039204Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elagolix in endometriosis, infertility, sponsored by Wake Forest University Health Sciences. Started Jan 2022; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosisinfertility
Beyond the preview
Go deeper on NCT04039204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04039204.